Geode Capital Management LLC Buys 198,118 Shares of Sabra Healthcare REIT, Inc. $SBRA

Geode Capital Management LLC grew its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 2.9% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,018,556 shares of the real estate investment trust’s stock after acquiring an additional 198,118 shares during the period. Geode Capital Management LLC’s holdings in Sabra Healthcare REIT were worth $132,949,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of SBRA. Principal Financial Group Inc. raised its stake in shares of Sabra Healthcare REIT by 21.6% during the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock valued at $472,617,000 after acquiring an additional 4,431,897 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Sabra Healthcare REIT by 1,019.8% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,005,374 shares of the real estate investment trust’s stock valued at $56,922,000 after acquiring an additional 2,736,993 shares in the last quarter. Balyasny Asset Management L.P. bought a new stake in shares of Sabra Healthcare REIT during the second quarter valued at approximately $49,955,000. Qube Research & Technologies Ltd raised its stake in shares of Sabra Healthcare REIT by 856.5% during the second quarter. Qube Research & Technologies Ltd now owns 1,398,965 shares of the real estate investment trust’s stock valued at $25,797,000 after acquiring an additional 1,252,708 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of Sabra Healthcare REIT by 33.7% during the third quarter. JPMorgan Chase & Co. now owns 3,589,253 shares of the real estate investment trust’s stock valued at $66,904,000 after acquiring an additional 903,841 shares in the last quarter. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Performance

Shares of SBRA stock opened at $17.67 on Friday. The firm has a market cap of $4.46 billion, a price-to-earnings ratio of 28.05, a PEG ratio of 1.36 and a beta of 0.64. The company’s 50 day moving average is $20.17 and its 200 day moving average is $19.69. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96. Sabra Healthcare REIT, Inc. has a 52-week low of $17.17 and a 52-week high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company had revenue of $211.74 million for the quarter, compared to analyst estimates of $209.20 million. During the same period last year, the company posted $0.37 earnings per share. Sabra Healthcare REIT’s revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, sell-side analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.51 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 6.8%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s payout ratio is currently 190.48%.

Analysts Set New Price Targets

SBRA has been the topic of several research reports. Wells Fargo & Company lifted their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a report on Monday. Citizens Jmp lifted their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a report on Wednesday, February 18th. Weiss Ratings lowered shares of Sabra Healthcare REIT from a “buy (a-)” rating to a “buy (b+)” rating in a report on Friday, May 1st. Truist Financial lifted their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a report on Friday, March 13th. Finally, Citigroup lifted their price objective on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, February 18th. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $22.40.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.